Gem Pharmaceuticals: Clinical Trials

4 trials sponsored by Gem Pharmaceuticals, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Completed 1, Terminated 1

Follow Gem Pharmaceuticals: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma
GPX-150 for Injection - Soft Tissue Sarcoma
Phase 2CompletedGem Pharmaceuticals222015-01-072018-01-10
Safety Study of GPX-150 in Patients With Solid Tumors
GPX-150 for Injection - Advanced Solid Tumors - Phase 1 Population
Phase 1CompletedGem Pharmaceuticals272008-01-012014-08-05
Study of GPX-100 in the Treatment of Metastatic Breast Cancer
GPX-100 (13-deoxydoxorubicin) - Breast Cancer, Metastasis
Phase 2TerminatedGem Pharmaceuticals402005-03-012007-01-09
GPX-100 in Treating Patients With Solid Tumors
GPX-100 - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedGem Pharmaceuticals1999-08-012013-04-23

Conditions studied

Breast Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Sarcoma (1)

Interventions

5-imino-13-deoxydoxorubicin (2)  ·  Injections (2)

Countries

United States (4)  ·  Bulgaria (1)

Top investigators

Frederick J. Dechow, PhD (1)  ·  John H. Ward, MD (1)  ·  Mohammed Milhem, MD (1)  ·  Raymond J Hohl, MD, PhD (1)